We are live on ! Find out more
TWST icon

Twist Bioscience
TWST

93 hedge funds and large institutions have $414M invested in Twist Bioscience in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

74% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 19

11.46% more ownership

Funds ownership: 48.14% → 59.6% (+11%)

11% more funds holding

Funds holding: 84 → 93 (+9)

11% more capital invested

Capital invested by funds: $374M → $414M (+$39.7M)

Holders
93
Holders Change
+9
Holders Change %
+10.71%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
22
Increased
33
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$16.5M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$11.4M
3
BlackRock
BlackRock
New York
+$7.27M
4
Millennium Management
Millennium Management
New York
+$6.93M
5
JP Morgan Chase
JP Morgan Chase
New York
+$4.42M

Top Sellers

Rank Fund Capital Flow
1
EA
Emerald Advisers
Pennsylvania
-$5.33M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$4.9M
3
IECM
Intrinsic Edge Capital Management
Illinois
-$4.22M
4
CM
Castleark Management
Illinois
-$3.4M
5
Barclays
Barclays
United Kingdom
-$1.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
76
Renaissance Technologies
New York
$206K +$229K +9,800 New
Bank of America
77
Bank of America
North Carolina
$167K -$120K -5,135 -39%
MLICM
78
Metropolitan Life Insurance Company (MetLife)
New York
$156K – – –
NIT
79
NumerixS Investment Technologies
British Columbia, Canada
$101K +$77.2K +3,300 +220%
Legal & General Group
80
Legal & General Group
United Kingdom
$97K +$25.3K +1,082 +30%
BNP Paribas Financial Markets
81
BNP Paribas Financial Markets
France
$53.7K -$7.63K -326 -11%
AIP
82
Ameritas Investment Partners
Nebraska
$39K – – –
Royal Bank of Canada
83
Royal Bank of Canada
Ontario, Canada
$33K +$37K +1,583 New
SO
84
STRS Ohio
Ohio
$29K – – –
Lazard Asset Management
85
Lazard Asset Management
New York
$22K +$25.1K +1,073 New
ASN
86
Advisory Services Network
Georgia
$17K +$9.36K +400 +100%
RIA
87
Realta Investment Advisors
Delaware
$13K – – –
Carson Wealth (CWM LLC)
88
Carson Wealth (CWM LLC)
Nebraska
$12K – – –
Canada Life
89
Canada Life
Manitoba, Canada
$11K +$12.4K +528 New
AG
90
Advisor Group
Arizona
$4K – – –
CFGS
91
Concourse Financial Group Securities
Alabama
$4K – – –
Daiwa Securities Group
92
Daiwa Securities Group
Japan
$4K +$4.35K +186 New
WCA
93
Windsor Creek Advisors
Vermont
$580 -$654K -27,960 -50%
CM
94
Castleark Management
Illinois
– -$3.4M -142,416 Closed
Invesco
95
Invesco
Georgia
– -$739K -30,951 Closed
LI
96
Leap Investments
Illinois
– -$394K -16,491 Closed
AR
97
Advisory Research
Illinois
– -$379K -15,877 Closed
Susquehanna International Group
98
Susquehanna International Group
Pennsylvania
– -$299K -12,504 Closed
FAM
99
Fred Alger Management
New York
– -$131K -5,500 Closed
TRCT
100
Tower Research Capital (TRC)
New York
– -$9K -395 Closed
1 2 3
4

TWST Hedge Fund Activity: Q4 2019 in Review

93 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2019, worth a combined $414M — up 11% from $374M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TWST positions and 7 closed out — a net gain of 15 holders — while 33 added to existing stakes and 19 trimmed.

The largest buyer was Capital World Investors, opening a new position worth an estimated $16.5M. The largest seller was Emerald Advisers, cutting an estimated $5.33M.

  • 93 institutional investors held Twist Bioscience (TWST) as of Q4 2019, up from 84 in Q3 2019.
  • Funds reported $414M of Twist Bioscience stock for Q4 2019, up 11% quarter-over-quarter.
  • 22 funds opened new Twist Bioscience positions in Q4 2019 and 7 closed out, a net change of +15 holders.
  • The largest Twist Bioscience buyer in Q4 2019 was Capital World Investors, an estimated $16.5M added.
  • The largest Twist Bioscience seller in Q4 2019 was Emerald Advisers, an estimated $5.33M sold.

Based on aggregated 13F filings for Q4 2019.